BGLC insider trading
NasdaqCM Basic MaterialsBioNexus Gene Lab Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Company website: www.bionexusgenelab.com
BGLC insider activity at a glance
FilingIQ has scored 5 insider transactions for BGLC since Aug 13, 2026. The most recent filing in our index is dated Aug 13, 2026.
Across the full history, 0 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
Other Basic Materials tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BGLC?
- FilingIQ tracks 5 Form 4 insider transactions for BGLC (BioNexus Gene Lab Corp), covering filings from Aug 13, 2026 onwards. 5 of those were filed in the last 90 days.
- Are BGLC insiders net buyers or net sellers?
- Across the full Form 4 history for BGLC, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BGLC insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is BGLC in?
- BioNexus Gene Lab Corp (BGLC) is classified in the Basic Materials sector, specifically Specialty Chemicals, with a current market capitalisation of $3.80M.
Methodology & sources
Every BGLC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.